Recombinant DNA Technology Market is Increasing at a Healthy CAGR of 6.9% During Forecast to 2023

 

Market Overview:

Recombinant DNA technology articulates DNA molecules from two different species that are introduced into the host organism to produce a new genetic combination with broad application. Market Research Future reported that the global recombinant DNA technology market is expected to attain a CAGR of 6.9% during the forecast 2017-2023.

Recombinant DNA technology has many applications in agriculture; to produce Bat cotton that protects the plants against pests. It is widely used in drug production, gene therapy, and clinical diagnosis.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5845

Growing demand for recombinant and genetically modified products for human health, nutrition and agriculture is expected to stimulate growth in the global recombinant DNA technology market over the forecast period. In addition, increased government funding for the use of Recombinant DNA Technology Market to address various food, health, and environmental issues is expected to stimulate market growth. Manufacturing companies that focus on product development using recombinant DNA technology for a variety of chronic diseases should accelerate market growth over the forecast period.

Major Players:

F. Hoffmann-La Roche Ltd, Profacgen, Amgen Inc., Pfizer Inc., Novartis AG, Genscript Biotech,Sanofi S.A., Novo Nordisk A/S, Merck & Co., Inc., Biogen Inc., Biocon Limited, Eli Lilly and Company, GlaxoSmithKline plc, Cibus,New England Biolabs, Horizon Discovery Group PLC, Boehringer Ingelheim,Monsanto Company, and others.

Segmentation:

·         The global Recombinant DNA Technology Market Analysis is broadly segmented based on multiple factors such as product, component, application, and end-user.

·         The product segment of the global recombinant DNA technology market is bifurcated into medical and non-medical. Further, the medical is sub-segmented into vaccines, therapeutic agents, and human proteins. The non-medical sub-segment is classified into specialty chemicals and biotech crops.

·         Based on the component, the global recombinant DNA technology market is bifurcated into cloning vector, expression system, and others. The cloning vector sub-segment is divided asYeast Artificial Chromosome (YAC), plasmid, cosmid, phage,Human Artificial Chromosome (HAC), and Bacterial Artificial Chromosome (BAC). The expression system sub-segment is classified into yeast, bacteria mammalian, and baculovirus/insect.

·         The application segment of the global recombinant DNA technology market is bifurcated into disease, food and agriculture, environment, andhealth.

·         The global recombinant DNA technology market, based on end-users, is also bifurcated as government research institutes, biotechnology companies, pharmaceuticals,and universities.

Regional Analysis:

The Americas has the largest share in the global recombinant DNA technology market due to the effective regulation of the registration of recombinant therapeutic products and other genetically modified (GM) products. Presence of some leading key players operating in this sector contributes to the growth of the recombinant DNA technology market in the region.

In addition, there is a growing need to improve recombinant protein production capacity several times in Europe. Growing demand for effective treatments for disease treatment and technological progress in this sector should lead to the growth of the European market for recombinant DNA technology.

Access Full Report Details @ https://www.marketresearchfuture.com/reports/recombinant-dna-technology-market-5845

 

The Asia Pacific region is expected to become the fastest-growing regional market for the global recombinant DNA technology market. Raising awareness about the growth of genetic diseases and disorders, developing health infrastructure, increasing healthcare spending, strengthening government initiatives to improve public health, and progress in the medical field stimulates market growth.

The Middle East and Africa are is saidto witness limited growth due to declining demand for genetic testing. The Middle East is experiencing significant growth compared to the African recombinant DNA technology market due to growing population, innovations in genetic testing and the growing number of chronic disease cases.

 

Comments

Post a Comment

Popular posts from this blog

Breathing Disorders And Treatments Market is Increasing at an Phenomenal CAGR During Forecast to 2023

  Market Overview: Breathing disorders are caused due to multiple factors that affect the respiratory system such as diseases such as allergies, infections and diseases like asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and others. Market Research Future (MRFR) has published a study report stating that the global breathing disorders and treatment market is registered to expand at a moderate pace and is anticipated to project high growth potential over the coming years.     Get a Free Sample @ https://www.marketresearchfuture.com/reports/breathing-disorders-treatment-market-1575     Market Drivers and Restraints: Increasing air pollution is one of the major causes that are triggering breathing disorders and respiratory diseases in highly populated regions. rise in prevalence of breathing disorders caused due to anthropogenic activities and other factors are inducing high demand for effective treatments all over the worl...
Read more

Dental Forceps Market is Rising at a Healthy CAGR of 5.2% During Forecast to 2024

Market Highlights: Numerous factors, such as the growing demand for dental forceps for performing several types of dental surgical procedures and the increasing number of dental practitioners and dental clinics, are anticipated to propel the growth of the market. Additionally, the growing incidence of dental diseases and the growing demand for cosmetic dentistry is likely to boost the growth of the market during the forecast period. According to the data published by the National Health Services (NHS), about 22.1 million adults were seen by an NHS dentist in the period, July 2016-July 2018. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/8012 The global Dental Forceps Market is anticipated to register a CAGR of 5.2 % during the forecast period of 2019 to 2024, with an estimated market value of USD 451.58 million in 2018. However, the availability of advanced dental equipment and limited reimbursement for dental surgeries are som...
Read more

Dental Forceps Market is Analytically Rising at a Healthy ACGR of 5.2% During Forecast to 2024

  Market Highlights: The global Dental Forceps Market is anticipated to register a CAGR of 5.2 % during the forecast period of 2019 to 2024, with an estimated market value of USD 451.58 million in 2018. However, the availability of advanced dental equipment and limited reimbursement for dental surgeries are some factors that may hinder the market growth during the assessment period. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/8012 Numerous factors, such as the growing demand for dental forceps for performing several types of dental surgical procedures and the increasing number of dental practitioners and dental clinics, are anticipated to propel the growth of the market. Additionally, the growing incidence of dental diseases and the growing demand for cosmetic dentistry is likely to boost the growth of the market during the forecast period. According to the data published by the National Health Services (NHS), about 22....
Read more